Pharmacology
Dr Jean-Sébastien Hulot is Professor of Medicine, Pharmacology at Université de PARIS Cité, France. He is leading a team at Paris Cardiovascular Research Center since 2019 and is Director of the Clinical Investigations Center at the Hôpital Européen Georges Pompidou, Paris Hospitals.
He is a medical cardiologist and received his MD degree at Paris University Hospitals and his PhD degree in clinical and experimental pharmacology at the René Descartes Paris 5 University. From 2010 to 2014, he served as an Associate Professor of Medicine, Cardiology at the Cardiovascular Research Center at Mount Sinai School of Medicine in New York, USA.
2021- Coordinator, Research Federation Prevent_Heart Failure, Inserm / APHP / Université de Paris ; website
2018- Team leader « Cellular, molecular and physiological mechanisms of heart failure », PARIS Cardiovascular Research Center, PARCC, INSERM UMR970, Paris
2018- Professor of medicine, Director Clinical Investigations Center, CIC-P 1418, Hôpital Européen Georges Pompidou, Paris
2013-2018 Professor of medicine, Institut Hospitalo-Universtaire ICAN (Institut de CardioMétabolisme et Nutrition ICAN), Pitié-Salpêtrière hospital, Paris
2010-2013 Associate Professor of Medicine, Cardiovascular Research Center, Director Pharmacogenomics & Personalized therapeutics, Mount Sinai School of Medicine, New York
2019-now Associate Editor, Journal of American College of Cardiology (IF: 27.203)
2020-22 President-elect, Groupe de Réflexion sur la Recherche Cardiovasculaire (G.R.R.C.), French Society of Cardiology
2022-now Member of the Pharmacology&Pharmacotherapy Committee, Heart Failure Association, ESC
2018-now Member of the HFmrEF/HFpEF Committee, Heart Failure Association, ESC
2017-2019 Member, AVIESAN, Working group on the development of human-based organoïds for preclinical testing
2016-20 Member-elect, Nucleus of the Working Group on Cellular Biology of the heart, ESC
2016-20 Member of the Translational Research Committee, Heart Failure Association, ESC
2008 Jeffrey Isner Award, Cardiovascular Cell Gene Therapy, New York
2012 Grand Prix Robert Debré, Recherche Médicale
2014 Fellow of the American Heart Association, Functional Genomics and translational biology Council
2015 Fellow of the European Society of Cardiology
2019-now Prize of Scientific Excellence